AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Tenofovir Disoproxil Fumarate/Emtricitabine in Ghana
2 products registered with FDA Ghana — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE TABLETS (Each film-coated tablet contains Tenofovir disoproxil fumarate/Emtricitabine 300mg/200mg) | UNKNOWN-2a4d326c | — | active | 1 Apr 2031 |
| TENOFOVIR DISOPROXIL FUMARATE/EMTRICITABINE TABLETS (Each film-coated tablet contains Tenofovir disoproxil fumarate/Emtricitabine 300mg/200mg) | UNKNOWN-0581b387 | — | active | 1 Apr 2031 |
Tenofovir Disoproxil Fumarate/Emtricitabine — FDA Ghana Registration Details
FDA Ghana (Ghana) has 2 registered products containing Tenofovir Disoproxil Fumarate/Emtricitabine, of which 2 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Tenofovir Disoproxil Fumarate/Emtricitabine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.